Fighting Fungi

Scientists from Howard Hughes Medical Institute in Ann Arbor, Michigan have made a discovery that may help us win the biomedical war against fungal pathogens. As published in Genes & Development, Dr. Martin Schrder and colleagues have uncovered a specific biological program which prevents the development of the pathogenic form of several fungi, and have thus paved the way for the design of new anti-fungal agents. Depending upon nutrient availability, many fungi are able to switch between two different morphological forms: a unicellular yeast form and a multicellular filament form. For a number of medically and agriculturally relevant fungi, the filament form is necessary for pathogenicity.

Ustilago maydis, Cryptococcus neoformans, and Candida albicans may not sound familiar, but the effects of these fungi certainly are. Well known to any farmer, Ustilago maydis is the cause of corn smut disease. Cryptococcus neoformans is responsible for meningitis. Candida albicans, the most prevalent yeast species in the human GI tract, causes vaginal yeast infections, oral thrush, and can invade tissues and produces fatal systemic infections in immunocompromised people. Under nitrogen-poor conditions, each of these fungi switch to filament form and thus become pathogenic. This physiological response to nutrient availability has been well documented. It is only now beginning to be understood.

Schrder and colleagues have discovered that the unfolded protein response (UPR) mediates this morphological response. The UPR is a cellular stress response, conserved from yeast to humans. Normally, proteins are folded into their proper conformations in the endoplasmic reticulum (ER) compartment of a cell. When unfolded or misfolded proteins accumulate in the ER, the UPR is activated to transiently decrease the level of protein production and ensure that proper folding occurs. Schrder and colleagues have demonstrated that an active UPR represses filament formation. Their experi

Contact: Nora Poppito
Cold Spring Harbor Laboratory

Page: 1 2

Related biology news :

1. Fighting Mycobacterium tuberculosis with structural proteomics
2. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
3. Fighting the spread of sudden oak death
4. Fighting the battle of the bulge in children
5. Fighting breast cancer at the molecular level
6. Fighting skin cancers with computers and technology
7. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
8. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
9. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
10. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells
11. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Post Your Comments:

(Date:9/25/2019)... HOUSTON (PRWEB) , ... September 25, 2019 , ... ... firm, is pleased to announce it ranked No. 3094 on Inc. Magazine’s annual ... Modality Solutions reported three-year revenue growth of 120 percent. Based on this growth, ...
(Date:9/25/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... of cancer research. , Deep Science Ventures was founded to create a better method ... from the start, both at the industry and biological level. , Through their ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... of 3D porous titanium spinal implants with the expansion of its proprietary Ti3D® ... more than tripling the number of cervical and lumbar instrumentation sets available for ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... (PRWEB) , ... September 30, 2019 , ... ... materials science newsletter from Rigaku Corporation , is now available online on ... to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents ...
(Date:9/24/2019)... Calif. (PRWEB) , ... September 24, 2019 , ... ... adipose-derived stem cell company, has completed training and site qualification for clinical trial ... process of recruitment and screening of potential clinical trial participants. , Clinical trial ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... STATION, N.J. (PRWEB) , ... September 16, 2019 , ... ... clearing reagents and kits that allow for the complete 3D characterization of tissues through ... Visikol has transitioned into an imaging, image analysis and advanced cell culture focused contract ...
Breaking Biology Technology:
Cached News: